Exacerbation of Idiopathic Interstitial Pneumonias Associated with Lung Cancer Therapy
Authors:
Open Access
- 1 January 2009
- journal article
- research article
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 48 (9) , 665-672
Abstract
Objective and Methods Idiopathic interstitial pneumonias (IIPs) frequently occur in association with lung cancer. However, there is no consensus on the best treatment of acute exacerbation of IIP in lung cancer patients (LC with IIP), including those with iatrogenic acute lung injury resulting from cancer treatments. We aimed to identify an appropriate strategy for treatment of this condition. We analyzed clinical features of 120 LC with IIP, retrospectively. Results The incidence of acute exacerbation related to anticancer treatment was 22.7%; when the incidence was examined separately for patients receiving chemotherapy or the best supportive care, the incidence was 20.0% and 31.3%, respectively. Additional investigations should be directed to finding suitable regimens for treatment of LC with IIP and the selection of appropriate patients with LC with IIP for chemotherapy. The incidence of acute exacerbation caused by combination regimens of carboplatin + paclitaxel or a platinum agent + etoposide was significantly lower than that of other regimens (0% vs. 18%, respectively; p=0.025, Fisher's Exact Test). Patients with high levels of C-reactive protein before chemotherapy had a significantly higher risk of developing acute exacerbation (odds ratio 5.60, p=0.028). Conclusion There was no evidence that anticancer treatment, including chemotherapy, should be avoided in LC with IIP. To establish an appropriate cancer treatment for LC with IIP, a prospective clinical study should be performed to evaluate various treatment modalities in a larger patient population.Keywords
This publication has 29 references indexed in Scilit:
- Acute Exacerbation of Interstitial Fibrosis After Pulmonary ResectionThe Annals of Thoracic Surgery, 2006
- Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcomesThe Journal of Thoracic and Cardiovascular Surgery, 2003
- Expression and alteration of ras and p53 proteins in patients with lung carcinoma accompanied by idiopathic pulmonary fibrosisCancer, 2002
- Clinical Examination of Acute Exacerbation of Idiopathic Interstitial Pneumonia (IIP) Combined With Lung Cancer After Anti-cancer Treatment.Haigan, 2001
- Serum anti-p53 autoantibodies from patients with idiopathic pulmonary fibrosis associated with lung cancerRespiratory Medicine, 2000
- Clinical significance of MCP‐1 levels in BALF and serum in patients with interstitial lung diseasesEuropean Respiratory Journal, 1999
- Acute Exacerbation of Idiopathic Interstitial Pneumonia Complicated by Lung Cancer, Caused by Treatment for Lung Cancer.Haigan, 1999
- Transforming Growth Factor β as a Predictor of Liver and Lung Fibrosis after Autologous Bone Marrow Transplantation for Advanced Breast CancerNew England Journal of Medicine, 1993
- New perspectives on basic mechanisms in lung disease. 1. Lung injury, inflammatory mediators, and fibroblast activation in fibrosing alveolitis.Thorax, 1992
- Cryptogenic fibrosing alveolitis and lung cancer.Thorax, 1980